secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syndax Pharmaceuticals Inc (SNDX)
CIK:        0001395937
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0001193125-23-296814
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syndax announces $200M public offering of common stock at $18.50/share
----------------------------------------------------------------------

- Issued 10,810,810 shares at $18.50; gross proceeds ~$200M ($230M with overallotment).
- Underwriters: Goldman Sachs, J.P. Morgan, Cowen and Company; deal expected to close Dec. 19, 2023.
- Lock-up agreement: company, directors, officers, certain stockholders restricted for 60 days.
- Offering made under existing S-3 shelf registration (File 333-254661).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1395937/000119312523296814/0001193125-23-296814-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1395937/000119312523296814/d50500d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-296814

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer